Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
ICD-10 P52.22 is a billable code used to indicate a diagnosis of intraventricular (nontraumatic) hemorrhage, grade 4, of newborn.
Intraventricular hemorrhage (IVH) is a serious condition that occurs in premature infants, particularly those born before 32 weeks of gestation. Grade 4 IVH is characterized by the presence of blood in the ventricles of the brain, which can lead to significant complications, including hydrocephalus and long-term neurological deficits. This condition is classified as nontraumatic, meaning it is not caused by external injury but rather by factors such as fragile blood vessels in the developing brain. The risk of IVH increases with decreasing gestational age and low birth weight. Clinically, it may present with symptoms such as altered consciousness, seizures, and abnormal muscle tone. Diagnosis is typically confirmed through cranial ultrasound, which can visualize the extent of the hemorrhage. Management may involve supportive care, monitoring for complications, and in some cases, surgical intervention to manage hydrocephalus. Early detection and intervention are crucial for improving outcomes in affected newborns.
Detailed neurological assessments, cranial imaging results, and treatment plans.
Management of premature infants with IVH in the NICU, monitoring for neurological outcomes.
Accurate grading of IVH is essential for coding and treatment planning.
Follow-up assessments of developmental milestones and neurological evaluations.
Pediatric follow-up for infants with a history of IVH, assessing for developmental delays.
Consideration of long-term outcomes and associated conditions in coding.
Used to monitor for IVH in premature infants.
Document indications for ultrasound and findings.
Neonatologists must ensure accurate reporting of ultrasound findings.
Infants with grade 4 IVH are at increased risk for long-term neurological deficits, including cerebral palsy, cognitive impairment, and developmental delays. Early intervention and follow-up care are crucial for optimizing outcomes.
